Vascular endotherial growth factor (VEGF) has been known as one of the most important factors stimulating angiogenesis in solid tumors, diabetic retinopathy, and rheumatoid arthritis. [1] [2] [3] VEGF secreted from tumor cells, macrophages, and other cell types binds to surface VEGF receptors such as KDR/Flk-1 and Flt-1 (receptor tyrosine kinases), and induces signal transduction for proliferation of endotherial cells. Now many antiangiogenic substances, such as antiVEGF and antiVEGFR antibodies, VEGF receptor inhibitors, inhibitors of signal transduction from VEGF, and growth inhibitors of endothelial cells, inhibitors of matrix metalloproteinase promoting vascular invasion, have been developed and are under clinical studies. 3) But angiogenesis inhibitors which inhibit transcription of VEGF have not been found. Transcription of VEGF is regulated by the level of a heterodimeric transcription factor, hypoxia-inducible factor 1 (HIF-1). HIF-1 is induced by hypoxia, and binds to the hypoxia responsive element (HRE) of promoters of genes such as VEGF, erythropoietin (Epo), glucose transporter-1, and glycolytic enzymes. In order to develop a screening system for isolation of a new inhibitor, we transfected a HIF-1-dependent VEGF promoter reporter plasmid constructed by Shibata et al. 4) to Chinese hamster ovary (CHO) cells, and an established stable clone named A4-4. In this plasmid, 5 copies of a 35-bp fragment containing HRE of VEGF were tandemly ligated to a 385 bp fragment excised from the 5Ј flanking region at position Ϫ1175 to Ϫ790 from the trasncription start site of human VEGF gene and the 32 bp sequence of the adenovirus E1b minimal promoter as a typical TATA box, and inserted into the pGL3 promoter vector as shown in Fig. 1 . In this paper we will describe the hypoxia response of the reporter gene in the CHO stable transformant like the transient transfection in HT1080 cells by the original constructor, 4) and the response to CoCl 2 , or other treatments not tested in the transient transfection.
MATERIALS AND METHODS
All the assays and the experiments were carried out at duplicate measurement, and at least three times, respectively.
Materials Materials used were as follows: Lactacystin, trichostatin A, and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] from Sigma Chemical Co., St. Louis, U.S.A.; MG-132 (Z-Leu-Leu-Leu H) from Carbiochem-Novabiochem Co.; Cobalt chloride, sodium nitroprusside, and sodium n-butyrate from Wako Pure Chemical industries, Ltd., Japan; NOR4 and carboxy-PTIO [2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide, sodium salt] from Dojindo Laboratories, Japan; Luciferase assay kit from Promega, Madison, U.S.A. All the other reagents used were special or cell culture grade.
Cell Culture, Transfection of the Reporter Gene, and Cloning of Stable Transformants CHO cells were cultured in a-MEM supplemented with 10% heat-inactivated fetal bovine serum (ICN Biomedicals) in a humidified 5% CO 2 /95% air (normoxia) incubator at 37°C. HIF-1-dependent VEGF promoter reporter gene construct (5xHRE/pGL3/ VEGF/E1b) 4) was kindly provided by Prof. M. Hiraoka (Kyoto University, Kyoto, Japan). CHO cells were transfected with the luciferase construct according to a conventional calcium phosphate coprecipitation technique. Stable transformants were selected in the presence of G418, and one of them named as A4-4 cells were used for further experiments. Cell number was determined with a Coulter Counter. Hypoxic Treatment Hypoxic incubation was performed in an air-tight chamber (Modulator incubator chamber from Forma Scientific Inc.) by changing into 90% N 2 gas with 5% CO 2 and 5% H 2 . Hypoxic condition was confirmed by the blue color of an O 2 indicator (Anaeromate-P, Nissui Pharamaceutical Co. Ltd., Tokyo). The chamber was stood in CO 2 incubator.
HIF-1-
Assay of Cytotoxicity and Expression of the Reporter Gene A4-4 cells were plated at a density of 10 4 /100 ml medium per well into Falcon 96-well microplates and cultured for 24 h to assure complete adherence of cells to plates. After hypoxic treatment cell number, cytotoxic effect and luciferase activity were determined in normoxia. Cytotoxicity was assayed by MTT assay. 5) For luciferase assay cells were washed and lysed according to the Luciferase Assay System from Promega. The activity was measured for 15 s by the Lumat LB 9507 luminometer (Berthold Japan).
RESULTS

Enhancement of Expression of VEGF Promoter Reporter Gene by Hypoxia
Effect of hypoxia on expression of 5xHRE/pGL3/VEGF/E1b was measured at various cell densities. Cells were seeded at 0.25-8.0ϫ10 4 in each well (0.38 cm 2 ) of 96-well microplates. After 24 h, hypoxia treatment was performed for 4 or 8 h. The same sets were placed in normoxia as a control. After the treatment luciferase activities and cell numbers were determined. As shown in Fig. 2 , the expression of cellular luciferase (luciferase activity/cell number) was almost the same level in normoxia except in the case of the highest cell density (initial; 8ϫ10 4 /well), where basal activity was 13-15 fold higher than that in the lower cell densities; also luciferase activity did not respond to hypoxia. No induction was seen with the empty vector in transient transfection by Shibata et al. 4) In the initial cell densities from 10 4 /well to 4ϫ10 4 /well hypoxic treatment for 4 h, cellular expression of the reporter than was increased 2.5-3.7 fold compared to the normoxic control. Hypoxia treatment for 8 h induced much stronger expression. In the initial cell density of 2ϫ10 4 /well the enhancement reached 30 fold. Hypoxia treatment for 24 h induced the strongest expression, causing growth inhibition (data not shown). From the following experiments, the cells were seeded at 10 4 /well, and hypoxic treatment was done for 8 h.
Effect of CoCl 2 on Expression of the VEGF Promoter Reporter Gene CoCl 2 is known to mimic hypoxia, induce HIF-1 expression, and stimulate Epo production in normoxia.
6) The upregulation of HIF-1 by CoCl 2 is caused suppression of iron (II)-dependent prolyl hydoxylase using O 2 to catalyze hydroxylation of proline residue of HIF-1a.
7) Effect of CoCl 2 on the reporter expression is shown in Fig. 3A . Incubation with CoCl 2 for 24 h in normoxia enhanced luciferase activity dependent on the CoCl 2 concentration. Treatment with 200 mM CoCl 2 for 24 h showed 35% growth inhibition, but the other treatments did not show cytotoxicity as shown in Fig. 3B . Two hundred mM CoCl 2 showed more than 10 times enhancement without correction for the decrease of cell number. These results are thought to be brought about by response of the promoter to HIF-1 induced by CoCl 2 .
Effect of Nitric Oxide Donors on Expression of the VEGF Promoter Reporter Gene While expression of inducible nitric oxide synthase is activated by HIF-1, 8) NO is known to suppress the activation of HIF-1 and induction of mRNA of VEGF 9) and Epo 10) by hypoxia like carbon monoxide. Effect of NO on the expression was determined by using NO donors, which spontaneously release NO. Cells were treated by NOR4 or nitroprusside simultaneously during the incubation in hypoxia for 8 h. As shown in Fig. 4 , both NO donors inhibited expression of the reporter gene in hypoxia as also noted for the transient expression of the similar HIFdependent reporter gene in Hep3B cells etc. 11) On the other hand, the NO radical scavenger, carboxy-PTIO, did not show any effect under 125 mM, but 500 mM showing 36% cytotoxic activity, gave 76% inhibition of expression.
Effect of Proteasome Inhibitors on Expression of the VEGF Promoter Reporter Gene Activation of HIF-1 by hypoxia is reported to be regulated by the protein level of HIF-1a, not by that of HIF-1b, the another subunit of HIF-1 as suggested from the results that the mRNA and protein level was not changed by hypoxia. 12) Turnover of HIF-1a is very rapid in normoxia, because the oxygen-dependent degradation domain of HIF-a is rapidly degraded by the ubiqutin-proteasome pathway when complexed with von Hippel-Lindau (VHL) tumor suppressor under normoxia. 13) Effect of proteasome inhibitors on the expression system was tested by lactacystin and MG-132. Both inhibitors did not give a significant effect in non-cytotoxic concentrations in normoxia and in hypoxia (data not shown) contrary to our expectation. Deroo et al. reported that proteasome inhibitor treatment interfered with production of luciferase protein. 14) By this reason, we might not ovserve proteasome inhibitor's effect in this assay.
Effect of Histone Deacetylase Inhibitors on the Expression of VEGF Promoter Reporter Gene Histone acetylase and deacetylase are known to play important roles in transcription by modulating chromatin structure and causes activation and repression of transcription, respectively. Histone deacetylase inhibitors stimulate expression of many genes such as Waf-1, 15) caspase-3 16) etc. Effect of trichostatin A and sodium n-butyrate on the expression of HIF-1 reporter is shown in Fig. 5 . Both histone deacetylase inhibitors accelerated expression of the reporter gene in hypoxia in non-cytotoxic concentrations. The higher concentrations of trichostatin A showing cytotoxicity brought about stronger inhibition of transcription than cytotoxic activity as also observed for the carboxy-PTIO and the proteasome inhibitors. It might be a matter of course because the MTT reaction, used as a parameter of cytotoxicity, determines the decrease of enzyme level due to cell death, and transcription is a preceding pathway of translation and cell death. 
DISCUSSION
The HIF-1-dependent VEGF promoter reporter gene in the stable transformant of CHO cells responded to hypoxia similarly to the transient transfection in a human cell line, HT1080. 4) This HIF-1-dependent VEGF promoter reporter gene assay seems to reflect VEGF transcription, because we found that some anthracyclins inhibited the reporter gene assay, expression of HIF-1a, and expression of VEGF mRNA (in preparation). Moreover Nicola et al., reported that geldanamaycin, an Hsp90 inhibitor, inhibited hypoxic induction of expression of mRNA and protein of VEGF by inducing degradation of HIF-1a protein. 24) Geldanamycin showed inhibiting activity in our reporter gene assay (data not shown).
The expression in normoxia was highly dependent on cell densities. In the highest initial cell density of 8ϫ10 4 /well, the cellular luciferase activity was increased almost 13-15 fold more than in the lower cell densities in normoxia, but did not respond to hypoxia. This phenomenon has been observed in erythropoietin production by HepG2 and Hep3B cells, 17) and by human renal carcinoma cells. 18) Though the reason is unclear, it might be caused due to intracellular space in cells reaching near to confluence is deficient in oxygen or factors 19, 20) in serum which activates transcription of VEGF or HIF-1a.
At low cell densities the expression of HIF-1-dependent VEGF promoter reporter gene in CHO cells was increased about 30 fold at the maximum by hypoxia treatment for 8 h as compared with normoxia as shown in Fig. 2 . CoCl 2 also increased the expression at normoxia more than 10 times as did hypoxia as shown in Fig. 3 . Thus the reporter gene showed HIF-1 dependent activation of the expression by responding to hypoxia and CoCl 2 . Nitric oxide donors, which are known to suppress the activation of HIF-1, 9,10) inhibited expression of the VEGF promoter reporter gene as expected.
Histone acetyltransferase and deacetylase regulate transcription as a coactivator or a subunit of basal transcription factor, and a corepressor, respectively, by changing the level of acetylated histone. A p300/CBP-HIF complex participates in hypoxia-induced VEGF and Epo mRNA synthesis. 21) Hypoxia-inducible transcription requires a multiprotein complex composed from HIF-1, CREB-1/ATF-1, and p300/CBP that binds to lactate dehydrogenase A promoter. 22 ) P300/CBP contains histone acetylase activity; histone deacetylase inhibitors, such as trichostatin A and sodium n-butyrate stimulate transcription of many genes such as Waf-1, gelsolin, cytokeratin A, caspase-3 etc., 16) and show biological activities including cell cycle arrest, detransformation, differentiation, and protection of colon cancer. As shown in Fig. 5 , trichostatin A and sodium n-butyrate also enhanced transcription of the VEGF promoter reporter gene in hypoxia, indicating that transcription of the gene is regulated by histone acetylase and deacetylase, too.
Angiogenesis is a new target of therapeutic agents in solid tumors, intraocular angiogenic diseases such as retinopathy in diabetes mellitus, retinal vein occlusion, prematurity etc., rheumatoid arthritis, and hyperthyroidism, because there is much evidence showing important roles of angiogenesis in progression of these diseases. VEGF and VEGF receptors are the most important among molecules involved in vascular growth. There are many strategies to inhibit angiogenesis as regards VEGF 3) as following: a neutralizing antibody against VEGF or VEGF receptors, an inhibitor of tyrosine kinase of VEGF receptor, an inhibitor of signal transduction from VEGF receptors. For a new strategy to search for a new angiogenesis inhibitor interfering with the transcription of VEGF, we transfected the HIF-1-dependent VEGF promoter reporter gene. Recently Rapisarda et al. 23) reported that 7 cell lines except for U251 human glioma cells when transfected the HIF-1-dependent VEGF promoter reporter gene lost hypoxic inducibility. The cell line established by us showed good hypoxia-dependent VEGF transcription. It will be useful for screening inhibitors of transcription of VEGF. NM-3, an orally active inhibitor of angiogenesis under way in Phase 2 study of cancer therapy in France and U.S.A., showed inhibition in this assay system as will be reported elsewhere.
